Gain Therapeutics (GANX) Stock Price & Financial Analysis
Gain Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Gain Therapeutics
What is the current stock price for GANX?
As of the latest trading session, GANX stock trades at $2.12. The 52-week range is $1.45–$4.34, with a day range of $2.09–$2.19.
What is the P/E ratio for GANX?
The P/E ratio (Price-to-Earnings) for GANX is shown in the Key Statistics section. This valuation metric helps compare Gain Therapeutics, Inc. to industry peers.
Does GANX pay dividends?
Gain Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GANX?
Based on 4 analysts, the consensus for GANX is Buy.
What is the market cap of GANX?
Gain Therapeutics's market capitalization is $89.5M, classifying it as a micro-cap company. Gain Therapeutics operates in the Healthcare sector within the Biotechnology industry.